Drugs / Prograf-XL
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT00720408 | Dec 2007 → Sep 2009 | disease related to solid organ transplantation, graft versus host disease | Astellas Pharma Inc | Completed | No outcome recorded |
| Phase 3 | NCT00717678 | Dec 2007 → Apr 2010 | graft versus host disease | Astellas Pharma Inc | Completed | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Prograf-XL | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00717678 ↗ |